| Product Code: ETC13342125 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Neglected Tropical Diseases Market was valued at USD 3.6 Billion in 2024 and is expected to reach USD 5.2 Billion by 2031, growing at a compound annual growth rate of 5.60% during the forecast period (2025-2031).
The Global Neglected Tropical Diseases Market encompasses a range of infectious diseases that primarily affect populations in low-income and developing countries. These diseases, such as malaria, dengue fever, and Chagas disease, often go unnoticed and lack sufficient attention and resources for research and development of treatments. The market is characterized by a limited number of available treatments, with many patients having limited access to healthcare facilities or medications. However, increasing awareness and advocacy efforts have led to a growing focus on addressing neglected tropical diseases, leading to increased funding for research and development initiatives. Pharmaceutical companies and nonprofit organizations are actively working to develop affordable and effective treatments, with the aim of improving healthcare outcomes and reducing the burden of these diseases on vulnerable populations globally.
The Global Neglected Tropical Diseases (NTDs) Market is witnessing a growing focus on research and development for innovative treatments and interventions, driven by increased awareness and funding from governments and organizations. Key trends include the development of novel drug therapies, advances in diagnostics and screening technologies, and collaborations between pharmaceutical companies and non-profit organizations to address the unmet medical needs of populations in low- and middle-income countries. Opportunities in the market lie in expanding access to affordable NTD treatments, leveraging digital health solutions for improved patient management, and investing in preventive measures such as vaccines and vector control programs. With a shift towards sustainable healthcare solutions and greater emphasis on global health equity, the NTD market presents prospects for growth and impact in the coming years.
The Global Neglected Tropical Diseases (NTDs) market faces several challenges, including limited awareness and funding, lack of access to healthcare in remote areas, and difficulties in developing and distributing treatments. NTDs predominantly affect marginalized populations in low-resource settings, making it challenging to raise awareness and secure sufficient funding for research and development. Additionally, the remote locations where NTDs are prevalent present obstacles in delivering healthcare services and medications to those in need. Furthermore, the complex nature of NTDs requires significant investment in research to develop effective treatments, and the lack of commercial incentives for pharmaceutical companies hinders the production and distribution of drugs for these diseases. Addressing these challenges requires coordinated efforts from governments, non-profit organizations, and the private sector to improve access to healthcare, increase funding, and drive innovation in the NTD market.
The Global Neglected Tropical Diseases (NTDs) market is primarily driven by increasing awareness and initiatives by governments, non-profit organizations, and pharmaceutical companies to address the burden of NTDs in low and middle-income countries. The growing prevalence of NTDs, coupled with the rising focus on healthcare access and affordability, has propelled investments in research and development of new treatments and interventions for these diseases. Furthermore, collaborations between public and private sectors, as well as advancements in technology and diagnostics, are driving innovation in the NTDs market. Additionally, favorable regulatory policies, funding support, and partnerships for drug development programs are contributing to the growth of the market for neglected tropical diseases.
Government policies related to the Global Neglected Tropical Diseases (NTDs) market often focus on promoting research and development efforts, increasing access to treatment and preventive measures, and fostering collaboration among stakeholders. Many governments provide funding and support for initiatives aimed at combating NTDs, such as mass drug administration programs, vaccine development, and public health campaigns. Additionally, some countries have regulatory frameworks in place to ensure the safety and efficacy of NTD treatments, as well as policies to incentivize pharmaceutical companies to invest in research for these diseases. International organizations, like the World Health Organization (WHO) and the Global Network for Neglected Tropical Diseases, also play a significant role in shaping government policies and coordinating efforts to address NTDs on a global scale.
The Global Neglected Tropical Diseases Market is expected to witness steady growth in the coming years due to increasing awareness, improved healthcare infrastructure in developing countries, and rising government initiatives to eradicate these diseases. Factors such as technological advancements, research and development activities, and collaborations between pharmaceutical companies and non-profit organizations are also likely to drive market growth. Additionally, the growing focus on preventive healthcare measures and the availability of innovative treatment options are expected to further boost the market. However, challenges such as lack of funding, limited access to healthcare in remote areas, and regulatory hurdles may hinder the market growth to some extent. Overall, the Global Neglected Tropical Diseases Market is projected to expand as efforts to address these diseases intensify.
In the Global Neglected Tropical Diseases Market, different regions exhibit varying dynamics. Asia accounts for a significant share due to high prevalence of diseases like dengue and malaria. North America and Europe are key players in terms of research and development initiatives, with a focus on innovation and advanced treatments. The Middle East and Africa region faces major challenges in terms of access to healthcare and resources for tackling neglected tropical diseases. Latin America is also a significant market with a growing focus on improving healthcare infrastructure and increasing awareness about these diseases. Overall, the regional landscape in the global neglected tropical diseases market is diverse, with each region facing unique opportunities and challenges in addressing these diseases effectively.
Global Neglected Tropical Diseases Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Neglected Tropical Diseases Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Neglected Tropical Diseases Market Revenues & Volume, 2021 & 2031F |
3.3 Global Neglected Tropical Diseases Market - Industry Life Cycle |
3.4 Global Neglected Tropical Diseases Market - Porter's Five Forces |
3.5 Global Neglected Tropical Diseases Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Neglected Tropical Diseases Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Global Neglected Tropical Diseases Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Global Neglected Tropical Diseases Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.9 Global Neglected Tropical Diseases Market Revenues & Volume Share, By Prevention, 2021 & 2031F |
3.10 Global Neglected Tropical Diseases Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Neglected Tropical Diseases Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Neglected Tropical Diseases Market Trends |
6 Global Neglected Tropical Diseases Market, 2021 - 2031 |
6.1 Global Neglected Tropical Diseases Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Neglected Tropical Diseases Market, Revenues & Volume, By Dengue, 2021 - 2031 |
6.1.3 Global Neglected Tropical Diseases Market, Revenues & Volume, By Chagas Disease, 2021 - 2031 |
6.1.4 Global Neglected Tropical Diseases Market, Revenues & Volume, By Leishmaniasis, 2021 - 2031 |
6.1.5 Global Neglected Tropical Diseases Market, Revenues & Volume, By Schistosomiasis, 2021 - 2031 |
6.1.6 Global Neglected Tropical Diseases Market, Revenues & Volume, By Lymphatic Filariasis, 2021 - 2031 |
6.2 Global Neglected Tropical Diseases Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Neglected Tropical Diseases Market, Revenues & Volume, By Blood Test, 2021 - 2031 |
6.2.3 Global Neglected Tropical Diseases Market, Revenues & Volume, By Imaging (X-Ray), 2021 - 2031 |
6.2.4 Global Neglected Tropical Diseases Market, Revenues & Volume, By Skin Biopsy, 2021 - 2031 |
6.2.5 Global Neglected Tropical Diseases Market, Revenues & Volume, By Urine Test, 2021 - 2031 |
6.2.6 Global Neglected Tropical Diseases Market, Revenues & Volume, By Ultrasound, 2021 - 2031 |
6.3 Global Neglected Tropical Diseases Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Neglected Tropical Diseases Market, Revenues & Volume, By Antiviral Therapy, 2021 - 2031 |
6.3.3 Global Neglected Tropical Diseases Market, Revenues & Volume, By Anti-Parasitic Drugs, 2021 - 2031 |
6.3.4 Global Neglected Tropical Diseases Market, Revenues & Volume, By Chemotherapy, 2021 - 2031 |
6.3.5 Global Neglected Tropical Diseases Market, Revenues & Volume, By Anthelmintics, 2021 - 2031 |
6.3.6 Global Neglected Tropical Diseases Market, Revenues & Volume, By Antiparasitic Treatment, 2021 - 2031 |
6.4 Global Neglected Tropical Diseases Market, Revenues & Volume, By Prevention, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Neglected Tropical Diseases Market, Revenues & Volume, By Mosquito Control, 2021 - 2031 |
6.4.3 Global Neglected Tropical Diseases Market, Revenues & Volume, By Vector Control, 2021 - 2031 |
6.4.4 Global Neglected Tropical Diseases Market, Revenues & Volume, By Insecticide Use, 2021 - 2031 |
6.4.5 Global Neglected Tropical Diseases Market, Revenues & Volume, By Sanitation Improvement, 2021 - 2031 |
6.4.6 Global Neglected Tropical Diseases Market, Revenues & Volume, By Mosquito Nets, 2021 - 2031 |
6.5 Global Neglected Tropical Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Neglected Tropical Diseases Market, Revenues & Volume, By Patients, 2021 - 2031 |
6.5.3 Global Neglected Tropical Diseases Market, Revenues & Volume, By Healthcare Providers, 2021 - 2031 |
6.5.4 Global Neglected Tropical Diseases Market, Revenues & Volume, By Public Health Agencies, 2021 - 2031 |
6.5.5 Global Neglected Tropical Diseases Market, Revenues & Volume, By Governments, 2021 - 2031 |
6.5.6 Global Neglected Tropical Diseases Market, Revenues & Volume, By Research Institutions, 2021 - 2031 |
7 North America Neglected Tropical Diseases Market, Overview & Analysis |
7.1 North America Neglected Tropical Diseases Market Revenues & Volume, 2021 - 2031 |
7.2 North America Neglected Tropical Diseases Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Neglected Tropical Diseases Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4 North America Neglected Tropical Diseases Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.5 North America Neglected Tropical Diseases Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.6 North America Neglected Tropical Diseases Market, Revenues & Volume, By Prevention, 2021 - 2031 |
7.7 North America Neglected Tropical Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Neglected Tropical Diseases Market, Overview & Analysis |
8.1 Latin America (LATAM) Neglected Tropical Diseases Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Neglected Tropical Diseases Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Neglected Tropical Diseases Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
8.4 Latin America (LATAM) Neglected Tropical Diseases Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
8.5 Latin America (LATAM) Neglected Tropical Diseases Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.6 Latin America (LATAM) Neglected Tropical Diseases Market, Revenues & Volume, By Prevention, 2021 - 2031 |
8.7 Latin America (LATAM) Neglected Tropical Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Neglected Tropical Diseases Market, Overview & Analysis |
9.1 Asia Neglected Tropical Diseases Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Neglected Tropical Diseases Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Neglected Tropical Diseases Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
9.4 Asia Neglected Tropical Diseases Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
9.5 Asia Neglected Tropical Diseases Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.6 Asia Neglected Tropical Diseases Market, Revenues & Volume, By Prevention, 2021 - 2031 |
9.7 Asia Neglected Tropical Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Neglected Tropical Diseases Market, Overview & Analysis |
10.1 Africa Neglected Tropical Diseases Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Neglected Tropical Diseases Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Neglected Tropical Diseases Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
10.4 Africa Neglected Tropical Diseases Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
10.5 Africa Neglected Tropical Diseases Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.6 Africa Neglected Tropical Diseases Market, Revenues & Volume, By Prevention, 2021 - 2031 |
10.7 Africa Neglected Tropical Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Neglected Tropical Diseases Market, Overview & Analysis |
11.1 Europe Neglected Tropical Diseases Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Neglected Tropical Diseases Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Neglected Tropical Diseases Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
11.4 Europe Neglected Tropical Diseases Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
11.5 Europe Neglected Tropical Diseases Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.6 Europe Neglected Tropical Diseases Market, Revenues & Volume, By Prevention, 2021 - 2031 |
11.7 Europe Neglected Tropical Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Neglected Tropical Diseases Market, Overview & Analysis |
12.1 Middle East Neglected Tropical Diseases Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Neglected Tropical Diseases Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Neglected Tropical Diseases Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Neglected Tropical Diseases Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
12.4 Middle East Neglected Tropical Diseases Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
12.5 Middle East Neglected Tropical Diseases Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.6 Middle East Neglected Tropical Diseases Market, Revenues & Volume, By Prevention, 2021 - 2031 |
12.7 Middle East Neglected Tropical Diseases Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Neglected Tropical Diseases Market Key Performance Indicators |
14 Global Neglected Tropical Diseases Market - Export/Import By Countries Assessment |
15 Global Neglected Tropical Diseases Market - Opportunity Assessment |
15.1 Global Neglected Tropical Diseases Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Neglected Tropical Diseases Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
15.3 Global Neglected Tropical Diseases Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
15.4 Global Neglected Tropical Diseases Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.5 Global Neglected Tropical Diseases Market Opportunity Assessment, By Prevention, 2021 & 2031F |
15.6 Global Neglected Tropical Diseases Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Neglected Tropical Diseases Market - Competitive Landscape |
16.1 Global Neglected Tropical Diseases Market Revenue Share, By Companies, 2024 |
16.2 Global Neglected Tropical Diseases Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here